Inventor · disambiguated record
Sarah Joanne Aves
Also filed as: AVES SARAH JOANNE
11 granted patents·46 citations·filing 2013–2023
90Inventor score
Top patents by PatentIndex Score
11 records- 0196US11680053B2Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2021·Granted Jun 20, 2023·2 cites·22 claims
- 0296US11584732B2Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2021·Granted Feb 21, 2023·4 cites·17 claims
- 0396US10981889B24-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2020·Granted Apr 20, 2021·5 cites·12 claims
- 0493US10246432B24-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Apr 2, 2019·9 cites·12 claims
- 0592US10584111B24-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2019·Granted Mar 10, 2020·7 cites·15 claims
- 0691US9676745B24-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsHEPTARES THERAPEUTICS LTD·Filed 2014·Granted Jun 13, 2017·10 cites·9 claims
- 0785US12415795B24-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsNXERA PHARMA UK LTD·Filed 2023·Granted Sep 16, 2025·0 cites·10 claims
- 0883US9555044B2Orexin receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2016·Granted Jan 31, 2017·3 cites·10 claims
- 0981US9850237B2Orexin receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Dec 26, 2017·2 cites·12 claims
- 1080US9249160B2Orexin receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2013·Granted Feb 2, 2016·3 cites·15 claims
- 1176US10316028B2Orexin receptor antagonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Jun 11, 2019·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Sarah Joanne Aves files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →